Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Multiple Endocrine Neoplasia Type 1

cabergoline has been researched along with Multiple Endocrine Neoplasia Type 1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Groß, U; Iacovazzo, D; Jungheim, K; Koehler, VF; Korbonits, M; Mann, A1
Nakakuki, T; Nanba, K; Shimatsu, A; Usui, T1
Camera, L; Carratù, A; Colao, A; de Luca di Roseto, C; Del Prete, M; Di Somma, C; Faggiano, A; Marciello, F; Marotta, V; Ramundo, V1

Other Studies

3 other study(ies) available for cabergoline and Multiple Endocrine Neoplasia Type 1

ArticleYear
Novel Germline p.Gly42Val
    Annals of clinical and laboratory science, 2017, Volume: 47, Issue:5

    Topics: Adult; Amino Acid Substitution; Antineoplastic Agents; Cabergoline; Combined Modality Therapy; Dopamine Agonists; Ergolines; Family Health; Germ-Line Mutation; Heterozygote; Humans; Male; Multiple Endocrine Neoplasia Type 1; Mutation, Missense; Pancreatectomy; Parathyroidectomy; Proto-Oncogene Proteins; Treatment Outcome

2017
Tension pneumocephalus after administration of two 0.25 mg cabergoline tablets in MEN1-related macroprolactinoma.
    BMJ case reports, 2013, Jun-07, Volume: 2013

    Topics: Adult; Antineoplastic Agents; Cabergoline; Ergolines; Humans; Magnetic Resonance Imaging; Male; Multiple Endocrine Neoplasia Type 1; Pneumocephalus; Prolactinoma; Tablets

2013
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas.
    Endocrine, 2014, Volume: 46, Issue:3

    Topics: Adult; Antineoplastic Agents; Cabergoline; Drug Therapy, Combination; Ergolines; Humans; Insulinoma; Male; Multiple Endocrine Neoplasia Type 1; Pancreatic Neoplasms; Peptides, Cyclic; Somatostatin; Treatment Outcome

2014